4th Quarter - Termination
PODESTA GROUP, INC. for NOVARTIS SERVICES, INC.
Firm
Client
Income
$30,000
Expenses
—
Terminated
Nov 30, 2017
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Health care policy and reform. Medical innovation. Cancer treatments. H.R.2641 - Promoting Life-Saving New Therapies for Neonates Act of 2017. Issues related to drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| PAUL BRATHWAITE | — |
| RANDALL GERARD | — |
Taxation/Internal Revenue Code TAX
Corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| KEVIN MCLAUGHLIN | — |
| DANA THOMPSON | — |
Labor Issues/Antitrust/Workplace LBR
S.540 - Mobile Workforce State Income Tax Simplification Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO | — |
| RANDALL GERARD | — |
| KEVIN MCLAUGHLIN | — |
| DANA THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.